BridgeBio Pharma (BBIO) PT Raised to $79 at Jefferies After Reporting Positive Encaleret Ph2 Data
Go back to BridgeBio Pharma (BBIO) PT Raised to $79 at Jefferies After Reporting Positive Encaleret Ph2 Data(NASDAQ: BBIO) | Delayed: 24.74 -0.21 (0.84%) | |||||
---|---|---|---|---|---|---|
Previous Close | $24.95 | 52 Week High | $ | |||
Open | $24.88 | 52 Week Low | $ | |||
Day High | $25.36 | P/E | N/A | |||
Day Low | $24.27 | EPS | $ | |||
Volume | 2,298,720 |